Sacramento, CA4 Active Studies

Hemophilia Clinical Trials in Sacramento, CA

Find 4 actively recruiting hemophilia clinical trials in Sacramento, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
508
Enrolling

Recruiting Hemophilia Studies in Sacramento

RecruitingSacramento, CANCT05568719

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatm...

263 participants
Pfizer
View Study Details
RecruitingSacramento, CANCT06379789

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study is researching an ex...

130 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingSacramento, CANCT05987449

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

WP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants wit...

60 participants
Hoffmann-La Roche
View Study Details
RecruitingSacramento, CANCT04647227

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Phase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors, 12 years of age and older, who are either on long term prophylactic treatment...

55 participants
American Thrombosis and Hemostasis Network
View Study Details

About Hemophilia Clinical Trials in Sacramento

Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.

There are currently 4 hemophilia clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 508 participants. Research is being sponsored by Pfizer, Regeneron Pharmaceuticals, Hoffmann-La Roche and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hemophilia Clinical Trials in Sacramento — FAQ

Are there hemophilia clinical trials in Sacramento?

Yes, there are 4 hemophilia clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What hemophilia treatments are being tested?

The 4 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.

Data updated March 2, 2026 from ClinicalTrials.gov